Intravitreal Faricimab for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration.
Pedro Luis GomezSloan W RushPublished in: Clinical ophthalmology (Auckland, N.Z.) (2022)
IVF can improve the visual and anatomic outcomes in a significant minority of treatment-resistant nAMD subjects previously managed with IVA. A greater follow-up period is needed to determine if such improvements can be maintained.